China Drugs for Malaria Market Research Report 2018

February 2018 | 104 pages | ID: C8D32649529QEN
QYResearch

Abstracts

The global Drugs for Malaria market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Drugs for Malaria development status and future trend in China, focuses on top players in China, also splits Drugs for Malaria by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Cipla
• Guilin Pharmaceutical
• IPCA Laboratories
• GlaxoSmithKline
• Mylan Labs
• Roche
• Novartis
• Sanofi Aventis
• Ajanta Pharma

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds

On the basis of the end users/application, this report covers

• Prevention
• Treatment
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Drugs for Malaria Market Research Report 2017

1 DRUGS FOR MALARIA OVERVIEW

1.1 Product Overview and Scope of Drugs for Malaria
1.2 Classification of Drugs for Malaria by Product Category
  1.2.1 China Drugs for Malaria Sales (K Pcs) Comparison by Type (2012-2022)
  1.2.2 China Drugs for Malaria Sales (K Pcs) Market Share by Type in 2016
  1.2.3 Aryl Aminoalcohol Compounds
  1.2.4 Antifolate Compounds
  1.2.5 Artemisinin Compounds
1.3 China Drugs for Malaria Market by Application/End Users
  1.3.1 China Drugs for Malaria Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Prevention
  1.3.3 Treatment
  1.3.4 Other
1.4 China Drugs for Malaria Market by Region
  1.4.1 China Drugs for Malaria Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Drugs for Malaria Status and Prospect (2012-2022)
  1.4.3 East China Drugs for Malaria Status and Prospect (2012-2022)
  1.4.4 Southwest China Drugs for Malaria Status and Prospect (2012-2022)
  1.4.5 Northeast China Drugs for Malaria Status and Prospect (2012-2022)
  1.4.6 North China Drugs for Malaria Status and Prospect (2012-2022)
  1.4.7 Central China Drugs for Malaria Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Drugs for Malaria (2012-2022)
  1.5.1 China Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2022)
  1.5.2 China Drugs for Malaria Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA DRUGS FOR MALARIA MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Drugs for Malaria Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Drugs for Malaria Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Drugs for Malaria Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
2.4 China Drugs for Malaria Market Competitive Situation and Trends
  2.4.1 China Drugs for Malaria Market Concentration Rate
  2.4.2 China Drugs for Malaria Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Drugs for Malaria Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA DRUGS FOR MALARIA SALES AND REVENUE BY REGION (2012-2017)

3.1 China Drugs for Malaria Sales (K Pcs) and Market Share by Region (2012-2017)
3.2 China Drugs for Malaria Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Drugs for Malaria Price (USD/Pcs) by Regions (2012-2017)

4 CHINA DRUGS FOR MALARIA SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China Drugs for Malaria Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
4.2 China Drugs for Malaria Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Drugs for Malaria Price (USD/Pcs) by Type (2012-2017)
4.4 China Drugs for Malaria Sales Growth Rate (%) by Type (2012-2017)

5 CHINA DRUGS FOR MALARIA SALES BY APPLICATION (2012-2017)

5.1 China Drugs for Malaria Sales (K Pcs) and Market Share by Application (2012-2017)
5.2 China Drugs for Malaria Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA DRUGS FOR MALARIA PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Cipla
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Drugs for Malaria Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Cipla Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Guilin Pharmaceutical
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Drugs for Malaria Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Guilin Pharmaceutical Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 IPCA Laboratories
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Drugs for Malaria Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 IPCA Laboratories Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Drugs for Malaria Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mylan Labs
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Drugs for Malaria Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan Labs Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Drugs for Malaria Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novartis
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Drugs for Malaria Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sanofi Aventis
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Drugs for Malaria Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sanofi Aventis Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Ajanta Pharma
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Drugs for Malaria Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Ajanta Pharma Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview

7 DRUGS FOR MALARIA MANUFACTURING COST ANALYSIS

7.1 Drugs for Malaria Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drugs for Malaria

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Drugs for Malaria Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA DRUGS FOR MALARIA MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Drugs for Malaria Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 China Drugs for Malaria Sales (K Pcs) Forecast by Type (2017-2022)
11.3 China Drugs for Malaria Sales (K Pcs) Forecast by Application (2017-2022)
11.4 China Drugs for Malaria Sales (K Pcs) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Drugs for Malaria Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Drugs for Malaria Sales (K Pcs) by Application (2016-2022)
Figure Product Picture of Drugs for Malaria
Table China Drugs for Malaria Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Drugs for Malaria Sales Volume Market Share by Types in 2016
Figure Aryl Aminoalcohol Compounds Product Picture
Figure Antifolate Compounds Product Picture
Figure Artemisinin Compounds Product Picture
Figure China Drugs for Malaria Sales (K Pcs) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Drugs for Malaria by Application in 2016
Figure Prevention Examples
Table Key Downstream Customer in Prevention
Figure Treatment Examples
Table Key Downstream Customer in Treatment
Figure Other Examples
Table Key Downstream Customer in Other
Figure South China Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2022)
Figure China Drugs for Malaria Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Drugs for Malaria Sales of Key Players/Manufacturers (2012-2017)
Table China Drugs for Malaria Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Drugs for Malaria Sales Share (%) by Players/Manufacturers
Figure 2017 China Drugs for Malaria Sales Share (%) by Players/Manufacturers
Table China Drugs for Malaria Revenue by Players/Manufacturers (2012-2017)
Table China Drugs for Malaria Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Drugs for Malaria Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Drugs for Malaria Revenue Market Share (%) by Players/Manufacturers
Table China Market Drugs for Malaria Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Drugs for Malaria Average Price of Key Players/Manufacturers in 2016
Figure China Drugs for Malaria Market Share of Top 3 Players/Manufacturers
Figure China Drugs for Malaria Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Drugs for Malaria Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Drugs for Malaria Product Category
Table China Drugs for Malaria Sales (K Pcs) by Regions (2012-2017)
Table China Drugs for Malaria Sales Share (%) by Regions (2012-2017)
Figure China Drugs for Malaria Sales Share (%) by Regions (2012-2017)
Figure China Drugs for Malaria Sales Market Share (%) by Regions in 2016
Table China Drugs for Malaria Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Drugs for Malaria Revenue Market Share (%) by Regions (2012-2017)
Figure China Drugs for Malaria Revenue Market Share (%) by Regions (2012-2017)
Figure China Drugs for Malaria Revenue Market Share (%) by Regions in 2016
Table China Drugs for Malaria Price (USD/Pcs) by Regions (2012-2017)
Table China Drugs for Malaria Sales (K Pcs) by Type (2012-2017)
Table China Drugs for Malaria Sales Share (%) by Type (2012-2017)
Figure China Drugs for Malaria Sales Share (%) by Type (2012-2017)
Figure China Drugs for Malaria Sales Market Share (%) by Type in 2016
Table China Drugs for Malaria Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Drugs for Malaria Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Drugs for Malaria by Type (2012-2017)
Figure Revenue Market Share of Drugs for Malaria by Type in 2016
Table China Drugs for Malaria Price (USD/Pcs) by Types (2012-2017)
Figure China Drugs for Malaria Sales Growth Rate (%) by Type (2012-2017)
Table China Drugs for Malaria Sales (K Pcs) by Applications (2012-2017)
Table China Drugs for Malaria Sales Market Share (%) by Applications (2012-2017)
Figure China Drugs for Malaria Sales Market Share (%) by Application (2012-2017)
Figure China Drugs for Malaria Sales Market Share (%) by Application in 2016
Table China Drugs for Malaria Sales Growth Rate (%) by Application (2012-2017)
Figure China Drugs for Malaria Sales Growth Rate (%) by Application (2012-2017)
Table Cipla Drugs for Malaria Basic Information List
Table Cipla Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Cipla Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Cipla Drugs for Malaria Sales Market Share (%) in China (2012-2017)
Figure Cipla Drugs for Malaria Revenue Market Share (%) in China (2012-2017)
Table Guilin Pharmaceutical Drugs for Malaria Basic Information List
Table Guilin Pharmaceutical Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Sales Market Share (%) in China (2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Revenue Market Share (%) in China (2012-2017)
Table IPCA Laboratories Drugs for Malaria Basic Information List
Table IPCA Laboratories Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure IPCA Laboratories Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure IPCA Laboratories Drugs for Malaria Sales Market Share (%) in China (2012-2017)
Figure IPCA Laboratories Drugs for Malaria Revenue Market Share (%) in China (2012-2017)
Table GlaxoSmithKline Drugs for Malaria Basic Information List
Table GlaxoSmithKline Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Sales Market Share (%) in China (2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Revenue Market Share (%) in China (2012-2017)
Table Mylan Labs Drugs for Malaria Basic Information List
Table Mylan Labs Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Mylan Labs Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Mylan Labs Drugs for Malaria Sales Market Share (%) in China (2012-2017)
Figure Mylan Labs Drugs for Malaria Revenue Market Share (%) in China (2012-2017)
Table Roche Drugs for Malaria Basic Information List
Table Roche Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Roche Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Roche Drugs for Malaria Sales Market Share (%) in China (2012-2017)
Figure Roche Drugs for Malaria Revenue Market Share (%) in China (2012-2017)
Table Novartis Drugs for Malaria Basic Information List
Table Novartis Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Novartis Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Novartis Drugs for Malaria Sales Market Share (%) in China (2012-2017)
Figure Novartis Drugs for Malaria Revenue Market Share (%) in China (2012-2017)
Table Sanofi Aventis Drugs for Malaria Basic Information List
Table Sanofi Aventis Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Sanofi Aventis Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Sanofi Aventis Drugs for Malaria Sales Market Share (%) in China (2012-2017)
Figure Sanofi Aventis Drugs for Malaria Revenue Market Share (%) in China (2012-2017)
Table Ajanta Pharma Drugs for Malaria Basic Information List
Table Ajanta Pharma Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Ajanta Pharma Drugs for Malaria Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Ajanta Pharma Drugs for Malaria Sales Market Share (%) in China (2012-2017)
Figure Ajanta Pharma Drugs for Malaria Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Malaria
Figure Manufacturing Process Analysis of Drugs for Malaria
Figure Drugs for Malaria Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Malaria Major Players/Manufacturers in 2016
Table Major Buyers of Drugs for Malaria
Table Distributors/Traders List
Figure China Drugs for Malaria Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure China Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Drugs for Malaria Price (USD/Pcs) Trend Forecast (2017-2022)
Table China Drugs for Malaria Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Drugs for Malaria Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Drugs for Malaria Sales Volume Market Share Forecast by Type in 2022
Table China Drugs for Malaria Sales (K Pcs) Forecast by Application (2017-2022)
Figure China Drugs for Malaria Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Drugs for Malaria Sales Volume Market Share Forecast by Application in 2022
Table China Drugs for Malaria Sales (K Pcs) Forecast by Regions (2017-2022)
Table China Drugs for Malaria Sales Volume Share Forecast by Regions (2017-2022)
Figure China Drugs for Malaria Sales Volume Share Forecast by Regions (2017-2022)
Figure China Drugs for Malaria Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources